Funding round

Funding round for Isomorphic Labs led by Greenoaks, Sequoia Capital

AI-driven drug discovery · London, United Kingdom

$5bnRound size according to the source

SourcingClub was not involved in this transaction.

Isomorphic Labs completes a Series C round of $5bn led by Greenoaks and Sequoia Capital. The company uses AI to develop new drugs and expands its drug candidate pipeline.

Deal-Radar editorial team · responsible:

Source from the same day: eqs-news.com , 17 Nov 2026

Who was involved.

Lead investor
Greenoaks, Sequoia Capital
Target
Isomorphic Labs, London
Type
Funding round
Country
United Kingdom
Source dated
17/11/2026
Round size
$5bn, according to the source

Deal-Radar no. 47-047 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.

November 2026 on the Deal-Radar.

40 of 269 deals so far are of the type Funding round.

  1. Strategic104
  2. Add-on41
  3. Funding round40
  4. Carve-out29
  5. Buy-out16
  6. Insolvency12
  7. Minority stake11
  8. Secondary8
  9. Succession6
  10. Merger2

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 17 November 2026.